Showing 1 - 7 results of 7 for search 'Nora Ruel', query time: 0.03s Refine Results
  1. 1
    NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center

    NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center by Daniel J. Kim, Dan Otap, Nora Ruel, Naveen Gupta, Naveed Khan, Tanya Dorff

    Published 2020-06-01
    Get full text
    Article
  2. 2
    CKD-EPI and cockcroft-gault equations identify similar candidates for neoadjuvant chemotherapy in muscle-invasive bladder cancer.

    CKD-EPI and cockcroft-gault equations identify similar candidates for neoadjuvant chemotherapy in muscle-invasive bladder cancer. by Sumanta K Pal, Nora Ruel, Sergio Villegas, Mark Chang, Kara DeWalt, Timothy G Wilson, Nicholas J Vogelzang, Bertram E Yuh

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study

    Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study by Dae Keun Kim, Jaspreet Singh Parihar, Young Suk Kwon, Sinae Kim, Brian Shinder, Nara Lee, Nicholas Farber, Thomas Ahlering, Douglas Skarecky, Bertram Yuh, Nora Ruel, Wun-Jae Kim, Koon Ho Rha, Isaac Yi Kim

    Published 2018-01-01
    Get full text
    Article
  4. 4
    Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer

    Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage... by Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. Mortimer

    Published 2023-02-01
    Get full text
    Article
  5. 5
    Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)

    Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epider... by Karen L. Reckamp, Paul H. Frankel, Nora Ruel, Philip C. Mack, Barbara J. Gitlitz, Tianhong Li, Marianna Koczywas, Shirish M. Gadgeel, Mihaela C. Cristea, Chandra P. Belani, Edward M. Newman, David R. Gandara, Primo N. Lara

    Published 2019-03-01
    Get full text
    Article
  6. 6
    Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California

    Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California by Nicholas J. Salgia, Alexander Chehrazi‐Raffle, JoAnn Hsu, Zeynep Zengin, Sabrina Salgia, Neal S. Chawla, Luis Meza, Jasnoor Malhotra, Nazli Dizman, Ramya Muddasani, Nora Ruel, Mary Cianfrocca, Jun Gong, Sidharth Anand, Victor Chiu, James Yeh, Sumanta K. Pal

    Published 2021-08-01
    Get full text
    Article
  7. 7
    Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer

    Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer by Bertram E. Yuh, Young Suk Kwon, Brian M. Shinder, Eric A. Singer, Thomas L. Jang, Sinae Kim, Mark N. Stein, Tina Mayer, Anna Ferrari, Nara Lee, Rahul R. Parikh, Nora Ruel, Wun-Jae Kim, Shigeo Horie, Seok-Soo Byun, Thomas E. Ahlering, Isaac Yi Kim

    Published 2019-09-01
    Get full text
    Article

Search Tools: